MYGN
Myriad Genetics, Inc. · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -3.1% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 966.11K | $4.16M | n/a | n/a |
| Q2 2026 | 84 | -4 | 70.39M | $401.85M | +6 | −11 |
| Q1 2026 | 92 | -3 | 73.19M | $329.45M | +3 | −6 |
| Q4 2025 | 95 | 0 | 80.50M | $495.06M | n/a | n/a |
| Q3 2025 | 19 | 0 | 56.51M | $408.57M | n/a | n/a |
| Q2 2025 | 16 | 0 | 51.45M | $273.22M | +1 | −1 |
| Q1 2025 | 13 | 0 | 25.12M | $222.86M | +1 | −1 |
| Q4 2024 | 13 | -1 | 27.01M | $370.33M | n/a | −1 |
| Q3 2024 | 13 | +3 | 18.94M | $518.67M | +3 | n/a |
| Q2 2024 | 10 | n/a | 22.76M | $556.69M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 14.88M | -1.3% | $107.58M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (pasif) | 7.88M | -14.8% | $56.99M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (pasif) | 4.98M | +3.5% | $35.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Millennium Management ✦ | 4.75M | -3.6% | $34.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 5 | Glenview Capital ✦ | 4.59M | 0.0% | $33.17M | 0.8% | Held | 6 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 4.56M | +1.1% | $32.96M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 3.62M | n/a | $26.15M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 8 | Geode Capital Management ✦ (pasif) | 2.23M | +0.1% | $16.09M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Goldman Sachs Group ✦ | 2.15M | n/a | $15.56M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | AQR Capital Management ✦ | 1.60M | +50.8% | $11.55M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 11 | Fisher Asset Management ✦ | 1.28M | -1.2% | $9.25M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 1.10M | n/a | $7.99M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 13 | Point72 Asset Management ✦ | 1.07M | +99.6% | $7.76M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 728.67K | +33.8% | $5.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 572.15K | -66.6% | $4.14M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Fidelity (FMR) ✦ | 398.23K | +14.2% | $2.88M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 17 | T. Rowe Price ✦ | 60.27K | +9.2% | $436,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Marshall Wace ✦ | 47.70K | -29.9% | $344,849 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 19 | Renaissance Technologies ✦ | 21.67K | -95.2% | $156,703 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 200 pemegang, 87.60M saham, $371.14M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.